Potential of these effects may be heightened in patients with breast cancer treated with hepatically metabolized chemotherapeutics (e.g., cyclophosphamide, paclitaxel, anthracyclines) or tyrosine kinase inhibitors in which drug-drug interaction-based elevation or lowering of enzyme activity can result in supra-therapeutic drug concentrations, accumulation of toxic metabolites and compromised detoxification of reactive oxygen species facilitating hepatocellular distress
Mechanistic diversity is the point
11201ES03, Yeasen, Shanghai, China) on a CFX384 real-time PCR system (Bio-Rad Laboratories, Hercules, CA, USA)
Intracellular GSH and -GC were extracted from the cells by 40 % ethanol for 2 h at 30 C
BPC-157 to peptyd skadajcy si z 15 aminokwasw, oparty na peptydzie naturalnie wystpujcym w ludzkim przewodzie pokarmowym